Codexis (CDXS) Long-Term Investments (2010 - 2026)
Codexis (CDXS) recorded quarterly Long-Term Investments of $2.5 million in Q1 2026, little changed quarter-over-quarter from $2.5 million in Q4 2025, and down 10.72% on a YoY basis from $2.8 million in Q1 2025.
Codexis (CDXS) Long-Term Investments (2010 - 2026) Analysis & Trends
Codexis' Long-Term Investments history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Long-Term Investments fell 10.72% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 10.72% YoY), while the FY2025 annual figure was $2.5 million, down 10.72% from the prior year.
- Long-Term Investments was $2.5 million for Q1 2026 at Codexis, roughly flat from $2.5 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $21.4 million in Q2 2023 to a low of $400000.0 in Q3 2023.
- Historically, Long-Term Investments has averaged $9.4 million across 5 years, with a median of $5.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments plunged 98.05% in 2023, then surged 1347.5% in 2024.
- A 5-year view of Long-Term Investments shows it stood at $20.5 million in 2022, then tumbled by 52.71% to $9.7 million in 2023, then sank by 71.15% to $2.8 million in 2024, then retreated by 10.72% to $2.5 million in 2025, then changed by 0.0% to $2.5 million in 2026.
- The last three Long-Term Investments figures came in at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 21.38 Mn |
| Mar 31, 2023 | 21.31 Mn |
| Dec 31, 2022 | 20.51 Mn |
| Sep 30, 2022 | 20.51 Mn |
| Jun 30, 2022 | 19.30 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 12.76 Mn |
| Jun 30, 2021 | 3.40 Mn |